These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35482422)

  • 1. Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination.
    Barman TK; Singh AK; Bonin JL; Nafiz TN; Salmon SL; Metzger DW
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
    Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
    mBio; 2011; 2(5):. PubMed ID: 21933918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.
    Smith AP; Williams EP; Plunkett TR; Selvaraj M; Lane LC; Zalduondo L; Xue Y; Vogel P; Channappanavar R; Jonsson CB; Smith AM
    Front Immunol; 2022; 13():894534. PubMed ID: 35634338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity.
    Achdout H; Vitner EB; Politi B; Melamed S; Yahalom-Ronen Y; Tamir H; Erez N; Avraham R; Weiss S; Cherry L; Bar-Haim E; Makdasi E; Gur D; Aftalion M; Chitlaru T; Vagima Y; Paran N; Israely T
    Nat Commun; 2021 Oct; 12(1):5819. PubMed ID: 34611155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection.
    Roberts S; Salmon SL; Steiner DJ; Williams CM; Metzger DW; Furuya Y
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
    Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
    Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.
    Karlsson EA; Meliopoulos VA; van de Velde NC; van de Velde LA; Mann B; Gao G; Rosch J; Tuomanen E; McCullers J; Vogel P; Schultz-Cherry S
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and Streptococcus pneumoniae.
    Tsukamoto T; Nakajima N; Sakurai A; Nakajima M; Sakurai E; Sato Y; Takahashi K; Kanno T; Kataoka M; Katano H; Iwata M; Doi Y; Suzuki T
    Emerg Infect Dis; 2021 Mar; 27(3):919-923. PubMed ID: 33443011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.
    Bao L; Deng W; Qi F; Lv Q; Song Z; Liu J; Gao H; Wei Q; Yu P; Xu Y; Qu Y; Li F; Xue J; Gong S; Liu M; Wang G; Wang S; Zhao B; Cong B; Qin C
    Signal Transduct Target Ther; 2021 May; 6(1):200. PubMed ID: 34016949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.
    Mitsi E; Reiné J; Urban BC; Solórzano C; Nikolaou E; Hyder-Wright AD; Pojar S; Howard A; Hitchins L; Glynn S; Farrar MC; Liatsikos K; Collins AM; Walker NF; Hill HC; German EL; Cheliotis KS; Byrne RL; Williams CT; Cubas-Atienzar AI; Fletcher TE; Adams ER; Draper SJ; Pulido D; Beavon R; Theilacker C; Begier E; Jodar L; Gessner BD; Ferreira DM
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35139037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.
    McIntosh EDG; Feemster K; Rello J
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-7. PubMed ID: 34406914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.
    Ghoneim HE; Thomas PG; McCullers JA
    J Immunol; 2013 Aug; 191(3):1250-9. PubMed ID: 23804714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.
    Metzger DW; Furuya Y; Salmon SL; Roberts S; Sun K
    J Infect Dis; 2015 Aug; 212(3):445-52. PubMed ID: 25649173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.